Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IHAT in Iron Deficient Premenopausal Women
NCT05950841Phase 3Completed
- Sponsor
- RDC Clinical
- Start
- Mar 2024
- Primary completion
- Feb 2025
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of iron hydroxide adipate tartrate in iron deficiency anemia (IDA), sponsored by RDC Clinical. Started Mar 2024; status: completed.
02
Drugs
iron hydroxide adipate tartrate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05950841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05950841.